HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.

AbstractAIMS:
Fos-related antigen 1 (Fra-1) is a member of the activator protein 1 (AP-1) transcription factor family. Our objective was to evaluate the role of Fra-1 expression in breast carcinoma progression and prognosis.
METHODS AND RESULTS:
Fra-1 expression was investigated by immunohistochemistry in two tissue microarrays containing, respectively, 85 ductal carcinoma in situ (DCIS) and 771 invasive ductal carcinoma (IDC) samples. Staining was observed in the nucleus and cytoplasm of the carcinomas, but only nuclear staining was considered to be positive. Fibroblasts associated with IDC were also Fra-1-positive. The frequency of Fra-1 positivity in IDC (22.8%) was lower than that in DCIS (42.2%). No association was found between Fra-1 and clinico-pathological variables in DCIS. In IDC, Fra-1 expression correlated with aggressive phenotype markers, including: high grade, oestrogen receptor negativity and human epidermal growth factor receptor 2 (HER-2) positivity (P=0.001, 0.015 and 0.004, respectively), and marginally with the presence of metastasis (P=0.07). Fra-1 was more frequently positive in basal-like (34%) and in HER-2-positive (38.5%) subtypes than in luminal subtypes. Fra-1 presence did not correlate with survival.
CONCLUSIONS:
A high frequency of Fra-1 in DCIS tumours may be associated with early events in breast carcinogenesis. Although Fra-1 expression correlated with features of a more aggressive phenotype in IDC, no relationship with overall survival was found.
AuthorsAngela Flavia Logullo, Mônica Maria Ágata Stiepcich, Cintia Aparecida Bueno de Toledo Osório, Sueli Nonogaki, Fátima Solange Pasini, Rafael Malagoli Rocha, Fernando Augusto Soares, Maria M Brentani
JournalHistopathology (Histopathology) Vol. 58 Issue 4 Pg. 617-25 (Mar 2011) ISSN: 1365-2559 [Electronic] England
PMID21371080 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 Blackwell Publishing Limited.
Chemical References
  • Antibodies, Monoclonal
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins c-fos
  • Transcription Factor AP-1
  • fos-related antigen 1
  • ERBB2 protein, human
  • Receptor, ErbB-2
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Breast Neoplasms (metabolism, pathology)
  • Carcinoma, Ductal, Breast (metabolism, pathology)
  • Carcinoma, Intraductal, Noninfiltrating (metabolism, pathology)
  • Cohort Studies
  • DNA-Binding Proteins (metabolism)
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Prognosis
  • Proto-Oncogene Proteins c-fos (metabolism)
  • Receptor, ErbB-2 (metabolism)
  • Retrospective Studies
  • Tissue Array Analysis
  • Transcription Factor AP-1 (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: